Allscripts Healthcare Solutions Inc (MDRX) Stake Lessened by Cwm LLC

Cwm LLC lowered its position in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 98.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,838 shares of the software maker’s stock after selling 228,031 shares during the period. Cwm LLC’s holdings in Allscripts Healthcare Solutions were worth $27,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Meeder Asset Management Inc. lifted its position in shares of Allscripts Healthcare Solutions by 539.1% in the 4th quarter. Meeder Asset Management Inc. now owns 3,368 shares of the software maker’s stock worth $32,000 after purchasing an additional 2,841 shares during the period. Tower Research Capital LLC TRC lifted its position in shares of Allscripts Healthcare Solutions by 580.9% during the 3rd quarter. Tower Research Capital LLC TRC now owns 17,861 shares of the software maker’s stock valued at $255,000 after acquiring an additional 15,238 shares during the period. Avestar Capital LLC lifted its position in shares of Allscripts Healthcare Solutions by 24.1% during the 3rd quarter. Avestar Capital LLC now owns 20,051 shares of the software maker’s stock valued at $270,000 after acquiring an additional 3,899 shares during the period. GAM Holding AG lifted its position in shares of Allscripts Healthcare Solutions by 70.2% during the 3rd quarter. GAM Holding AG now owns 19,744 shares of the software maker’s stock valued at $281,000 after acquiring an additional 8,141 shares during the period. Finally, Creative Planning lifted its position in shares of Allscripts Healthcare Solutions by 53.5% during the 3rd quarter. Creative Planning now owns 36,293 shares of the software maker’s stock valued at $517,000 after acquiring an additional 12,650 shares during the period.

MDRX opened at $11.36 on Friday. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.94 and a current ratio of 0.94. Allscripts Healthcare Solutions Inc has a 1-year low of $8.54 and a 1-year high of $14.97. The firm has a market cap of $1.98 billion, a price-to-earnings ratio of 24.17, a price-to-earnings-growth ratio of 1.70 and a beta of 1.40.

In other Allscripts Healthcare Solutions news, CEO Paul Black acquired 24,765 shares of the stock in a transaction on Wednesday, December 12th. The shares were purchased at an average price of $10.10 per share, for a total transaction of $250,126.50. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Richard J. Poulton sold 60,000 shares of the company’s stock in a transaction on Thursday, December 13th. The stock was sold at an average price of $9.82, for a total transaction of $589,200.00. Following the transaction, the president now owns 479,520 shares in the company, valued at approximately $4,708,886.40. The disclosure for this sale can be found here. In the last 90 days, insiders have acquired 37,728 shares of company stock worth $380,972. Corporate insiders own 1.10% of the company’s stock.

A number of research analysts recently issued reports on MDRX shares. JPMorgan Chase & Co. downgraded shares of Allscripts Healthcare Solutions from an “overweight” rating to a “neutral” rating and dropped their target price for the company from $16.00 to $12.00 in a research report on Friday, November 2nd. ValuEngine downgraded shares of Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Friday, November 2nd. SunTrust Banks downgraded shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research report on Friday, November 2nd. Cantor Fitzgerald downgraded shares of Allscripts Healthcare Solutions from an “overweight” rating to a “neutral” rating and set a $12.00 target price on the stock. in a research report on Thursday, November 1st. Finally, Citigroup dropped their target price on shares of Allscripts Healthcare Solutions from $19.00 to $17.00 and set a “buy” rating on the stock in a research report on Friday, November 2nd. Seven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $15.31.

TRADEMARK VIOLATION WARNING: “Allscripts Healthcare Solutions Inc (MDRX) Stake Lessened by Cwm LLC” was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.themarketsdaily.com/2019/02/09/allscripts-healthcare-solutions-inc-mdrx-stake-lessened-by-cwm-llc.html.

Allscripts Healthcare Solutions Profile

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Recommended Story: What is net income?

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions Inc (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply